Allergan India > Products > Eye care
Product Search

Product details

LUMIGAN® 0.01%

With Prescription

  • Group

    Glaucoma

  • Dosage And Administration

    The recommended dosage is one drop in the affected eye(s) once daily in the evening. LUMIGAN® 0.01% (bimatoprost ophthalmic solution) should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering effect.

    Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours.

    LUMIGAN® may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

  • Each mL contains

    Solution containing 0.1 mg/mL bimatoprost (LUMIGAN® 0.01%)

    Indications and Usage

    LUMIGAN® 0.01% (bimatoprost ophthalmic solution) is indicated to reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

  • How supplied

    LUMIGAN® (bimatoprost ophthalmic solution) 0.01% is supplied sterile in opaque white low density polyethylene ophthalmic dispenser bottles and tips with turquoise polystyrene caps in the following sizes: 3 mL fill in a 5 mL container.

  • SPC

    LUMIGAN® 0.01%